Connect Biopharma HldgsCNTB
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 12 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were BML Capital Management, LLC ($3.1M), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ($776K) and Renaissance Technologies ($323K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $24K |
| Exits | 2 | $19K |
All 13F filers, Q1 2024 → Q2 2024: 28,768 shares bought and 999,772 shares sold, net −971,004 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| BML Capital Management, LLC | 2.27% | Reduce -0.9% | 2,043,248 | $3.1M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | No change | 510,701 | $776K |
| Renaissance Technologies | 0.00% | Reduce -11.5% | 212,300 | $323K |
| BlackRock Inc. | 0.00% | Reduce -90.0% | 103,891 | $158K |
| Keudell/Morrison Wealth Management | 0.01% | Add +63.5% | 32,200 | $49K |
| Geode Capital Management, LLC | 0.00% | No change | 27,961 | $43K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $30K |
| Royal Bank of Canada | 0.00% | New | 12,700 | $19K |
| Rhumbline Advisers | 0.00% | Reduce -42.5% | 9,500 | $14K |
| Morgan Stanley | 0.00% | New | 3,568 | $5K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $184 |
| Qube Research & Technologies Ltd | 0.00% | No change | 46 | $70 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.